These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6819916

  • 1. Some effects of aldose reductase inhibition upon the eyes of long-term streptozotocin-diabetic rats.
    Poulsom R, Boot-Handford RP, Heath H.
    Curr Eye Res; ; 2(5):351-5. PubMed ID: 6819916
    [No Abstract] [Full Text] [Related]

  • 2. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF, Akagi Y, Kinoshita JH.
    Diabet Med; 1985 May; 2(3):194-6. PubMed ID: 2952419
    [No Abstract] [Full Text] [Related]

  • 3. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H, Yaginuma T, Mizuno A.
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract] [Full Text] [Related]

  • 4. [The intraocular penetration of aldose reductase inhibitor in rat eyes].
    Kojima M, Sasaki K.
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):57-62. PubMed ID: 3133930
    [No Abstract] [Full Text] [Related]

  • 5. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy.
    Mizuno A, Nozawa H, Yaginuma T, Matsuzaki H, Ozaki Y, Iriyama K.
    Exp Eye Res; 1987 Jul; 45(1):185-6. PubMed ID: 3115805
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of aldose reductase in five tissues of the streptozotocin-diabetic rat.
    Poulsom R, Heath H.
    Biochem Pharmacol; 1983 May 01; 32(9):1495-9. PubMed ID: 6407486
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats.
    Poulsom R, Mirrlees DJ, Earl DC, Heath H.
    Exp Eye Res; 1983 May 01; 36(5):751-60. PubMed ID: 6406254
    [Abstract] [Full Text] [Related]

  • 9. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
    Datiles MB, Fukui H.
    Curr Eye Res; 1989 Mar 01; 8(3):233-7. PubMed ID: 2523284
    [Abstract] [Full Text] [Related]

  • 10. Altering the course of cataracts in diabetic rats.
    Fukushi S, Merola LO, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1980 Mar 01; 19(3):313-5. PubMed ID: 6766909
    [Abstract] [Full Text] [Related]

  • 11. [A study of the limitations of ARI treatment of streptozotocin-induced diabetic cataracts].
    Kojima M, Sasaki K.
    Nippon Ganka Gakkai Zasshi; 1986 Dec 01; 90(12):1669-73. PubMed ID: 2950739
    [No Abstract] [Full Text] [Related]

  • 12. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E.
    Diabetes; 1985 Jan 01; 34(1):15-21. PubMed ID: 3917257
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
    Funada M, Okamoto I, Fujinaga Y, Yamana T.
    Nippon Ganka Gakkai Zasshi; 1985 Oct 01; 89(10):1111-9. PubMed ID: 3938182
    [No Abstract] [Full Text] [Related]

  • 20. [Morphological classification of the prevention by aldose reductase inhibitor of rat galactosemic cataract].
    Akagi Y, Ikebe H, Terubayashi H, Takahashi Y, Tsuji T.
    Nippon Ganka Gakkai Zasshi; 1989 Apr 01; 93(4):494-500. PubMed ID: 2508449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.